|
1
|
Giri VN, Oliver TK, Rumble RB, Geisel RL. Reply to X. Luo et al. J Clin Oncol 2023; 41:1150-1151. [PMID: 36315930 DOI: 10.1200/jco.22.02126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023] Open
Affiliation(s)
- Veda N Giri
- Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA
| | - Thomas K Oliver
- Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA
| | - R Bryan Rumble
- Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA
| | - Rachel L Geisel
- Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA
| |
Collapse
|